Anti-Caveolin-1 Antibodies as Anti-Prostate Cancer Therapeutics

Hybridoma
doi 10.1089/hyb.2011.0100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Anti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer

Drug Development Research
Drug Discovery
2013English

Discovery of Anti-Claudin-1 Antibodies as Candidate Therapeutics Against Hepatitis C Virus

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2015English

Anti-Hmgb1 Antibodies and Alpha-7 Agonists as Experimental Therapeutics as BW Countermeasures

2006English

The Promise of Anti-ErbB3 Monoclonals as New Cancer Therapeutics

Oncotarget
Oncology
2012English

Prostate Cancer Responds to Anti–PD-1–ctla4 Combo

Cancer Discovery
Oncology
2019English

An Evaluation of Minor Groove Binders as Anti-Lung Cancer Therapeutics

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2016English

Anti-Idiotype Antibodies in Cancer Treatment

Frontiers Research Topics
2013English

Rapalogs and mTOR Inhibitors as Anti-Aging Therapeutics

Journal of Clinical Investigation
Medicine
2013English

Anti-Transcription Factor RNA Aptamers as Potential Therapeutics

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy